SCHEMBL6323192

SCHEMBL6323192

ONCc1c[nH]nc1-c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.39
THRB P10828 1/20 0.39
ALOX15 P16050 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.37
ALDH1A1 P00352 5/20 0.36
MAPT P10636 3/20 0.36
GFER P55789 1/20 0.36
KDM4E B2RXH2 3/20 0.35
LMNA P02545 2/20 0.35
RAB9A P51151 2/20 0.35
GAA P10253 3/20 0.34
HPGD P15428 3/20 0.34
ALPL P05186 1/20 0.34
TTK P33981 1/20 0.34
MAPK10 P53779 1/20 0.34
ATM Q13315 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
NPC1 O15118 1/20 0.33
HSD17B10 Q99714 1/20 0.33
AKT1 P31749 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17790236 0.83 ALOX15 (0.39) IDO1ALOX15SMN1; SMN2ALDH1A1MAPT
SCHEMBL13614185 0.80 GAA (0.41) ALOX15SMN1; SMN2ALDH1A1MAPTGFER
SCHEMBL13958922 0.80 ALDH1A1 (0.39) ALOX15SMN1; SMN2ALDH1A1MAPTGFER
SCHEMBL11123121 0.77 ALOX15 (0.43) IDO1ALOX15SMN1; SMN2ALDH1A1MAPT
SCHEMBL18901018 0.77 DPP4 (0.44) IDO1ALOX15SMN1; SMN2ALDH1A1MAPT
SCHEMBL28583866 0.77 ALOX15 (0.43) IDO1ALOX15SMN1; SMN2ALDH1A1MAPT
SCHEMBL28861332 0.77 ALOX15 (0.43) IDO1ALOX15SMN1; SMN2ALDH1A1MAPT
SCHEMBL5381933 0.76 KDM4E (0.49) ALOX15SMN1; SMN2ALDH1A1MAPTKDM4E
SCHEMBL2219196 0.75 MEN1 (0.51) ALOX15SMN1; SMN2ALDH1A1LMNANPSR1
SCHEMBL18095847 0.74 HRH4 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2005-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors MAP3K9, MAP3K19, MAP4K2 IDO1 855/4885THRB 2605/4885ALOX15 2753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.